BONMASSAR, ENZO
 Distribuzione geografica
Continente #
NA - Nord America 30.108
EU - Europa 2.222
AS - Asia 581
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 8
AF - Africa 2
OC - Oceania 1
Totale 32.935
Nazione #
US - Stati Uniti d'America 30.098
DE - Germania 488
UA - Ucraina 477
CN - Cina 353
IT - Italia 263
IE - Irlanda 250
FR - Francia 183
GB - Regno Unito 174
KR - Corea 168
SE - Svezia 128
PL - Polonia 91
FI - Finlandia 89
RU - Federazione Russa 32
BE - Belgio 23
IN - India 21
KG - Kirghizistan 17
EU - Europa 11
JP - Giappone 9
CA - Canada 6
IL - Israele 6
BR - Brasile 4
CL - Cile 4
MK - Macedonia 4
MX - Messico 4
NL - Olanda 4
VN - Vietnam 4
AL - Albania 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
ES - Italia 2
NO - Norvegia 2
RO - Romania 2
SG - Singapore 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
SC - Seychelles 1
Totale 32.935
Città #
Woodbridge 9.615
Houston 7.678
Wilmington 7.676
Ann Arbor 936
Fairfield 700
Chandler 484
Ashburn 433
Jacksonville 421
Seattle 285
Cambridge 261
Dublin 243
Dearborn 211
Medford 194
Beijing 190
New York 141
Rome 102
Lawrence 92
Kraków 91
Mülheim 79
San Diego 44
Falls Church 41
Boardman 35
Zhengzhou 34
Menlo Park 27
Milan 26
Mountain View 25
Brussels 23
Redwood City 23
University Park 22
Hefei 19
San Mateo 19
Norwalk 18
Hangzhou 14
Guangzhou 13
Nürnberg 12
Verona 12
Palo Alto 11
Engelhard 10
Kunming 10
London 10
Auburn Hills 9
Detroit 9
Jinan 7
Nanchang 7
Nanjing 7
Pune 6
Redmond 6
Washington 6
Napoli 5
Tappahannock 5
Toronto 5
Austin 4
Chicago 4
Hanoi 4
Hyderabad 4
Shanghai 4
Shenyang 4
Absecon 3
Changsha 3
Florence 3
Kilburn 3
Los Angeles 3
Mexico City 3
Phoenix 3
Saint Petersburg 3
Shaoxing 3
Shenzhen 3
Simi Valley 3
São Paulo 3
Yellow Springs 3
Ypsilanti 3
Baotou 2
Carmagnola 2
Chaoyang 2
Creede 2
Fuzhou 2
Helsinki 2
Indiana 2
Jinhua 2
Leawood 2
Mesagne 2
Missaglia 2
Naples 2
Ningbo 2
Padova 2
Reggio Calabria 2
San Cesareo 2
San Francisco 2
Sassari 2
Secaucus 2
Siena 2
Skopje 2
Sulmona 2
Tirana 2
Tokyo 2
Wenzhou 2
Xian 2
Yalta 2
Ürümqi 2
Augusta 1
Totale 30.475
Nome #
Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells 441
Focus on Fotemustine 436
Combined effects of protein kinase inhibitors and 5-fluorouracil on CEA expression in human colon cancer cells 436
Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence 434
Bacillus Calmette-Guerin down-regulates CD1b induction by granulocyte-macrophage colony stimulating factor in human peripheral blood monocytes 431
INVECCHIAMENTO, IMMUNITÀ E FARMACI 427
Drug-induced increase of carcinoembryonic antigen expression in cancer cells 424
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site 418
Exogenous Control of the Expression of Group I CD1 Molecules Competent for Presentation of Microbial Nonpeptide Antigens to Human T Lymphocytes 417
Rifampin increases cytokine-induced expression of the CD1b molecule in human peripheral blood monocytes 414
Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds 412
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL) 411
Circulating tumor cells in colorectal cancer patients 411
Cisplatin increases sensitivity of human leukemic blasts to triazene compounds 409
Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia 407
Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV) 407
Chemical xenogenization: antigenic changes of cancer cells induced by triazene compounds 406
In vitro infection of CD4+ T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers 406
Adjuvant treatment of breast cancer: a pilot immunochemotherapy study with CMF, interleukin-2 and interferon alpha 405
Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3'-azido-3'-deoxythymidine 405
Effect of prostaglandin A1 on proliferation and telomerase activity of human melanoma cells in vitro 405
Drug-induced modulation of carcinoembryonic antigen (CEA) expression in neoplastic cells from a patient with rectal cancer 404
Staurosporine increases carcinoembryonic antigen expression in a human colon cancer cell line 403
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 401
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells 401
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 400
Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: Influence of 3'-azido-3'-deoxythymidine 400
The antiretroviral agent saquinavir enhances hTERT expression and telomerase activity in human T leukaemia cells in vitro 399
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy 397
Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines 396
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 396
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro 395
Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon 394
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells 392
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 390
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy 390
5-Fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 389
Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells 388
Pharmacological modulation of carcinoembryonic antigen in human cancer cells: studies with staurosporine 382
IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3' dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro 382
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes 381
Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells 380
Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen 378
COMPARATIVE ANTIVIRAL AND ANTIPROLIFERATIVE ACTIVITY OF PGA1 AND PGJ2 AGAINST HTLV-I-INFECTED MT-2 CELLS 376
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype 375
Influence of Mycobacterium bovis bacillus Calmette Guérin on in vitro induction of CD1 molecules in human adherent mononuclear cells 373
Inhibition of O-6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic coils to apoptosis induced by temozolomide 371
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase 369
Interfacing Sca-1pos mesenchymal stem cells with biocompatible scaffolds with different chemical composition and geometry 367
In vitro combined effects of human interferons and interleukin-2 on natural cell-mediated cytotoxicity 366
Flow cytometric method for the evaluation of the biological activity of thymic hormones 365
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients 363
HIV-Tat down-regulates telomerase activity in the nucleus of human CD4+ T cells [1] 361
Triazene compounds in the treatment of acute myeloid leukemia: a short review and a case report 361
Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemic cells 359
Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester 355
Clinical applications of telomerase in cancer treatment 355
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 353
hMSH3 overexpression and cellular response to cytotoxic anticancer agents 353
In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds 350
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro 349
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents 349
In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds 347
Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples 346
Telomerase as a marker of tumor cell viability: A new approach for in vitro chemosensitivity assays? 343
Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice 338
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 337
Evaluation of telomerase activity in nasal polyps 336
Transient HTLV-I infection of a human glioma cell line following cell-free exposure 335
Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway 335
Involvement of the mismatch repair system in temozolomide-induced apoptosis 335
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 333
Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-I 331
Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: Effect of 5-fluorouracil 321
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 320
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells 318
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 315
Natural cell-mediated cytotoxicity: a micro assay suitable for clinical tests 313
Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes 312
Spindle cells from AIDS-associated Kaposi's sarcoma (KS) lesions express telomerase activity that is enhanced by KS progression factors. 310
A miniaturized cell-mediated cytotoxicity assay with human effector mononuclear cells 303
Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-Ribose) polymerase 300
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 297
Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon 294
Dacarbazine-induced immunogenicity of a murine leukemia is attenuated in cells transfected with mutated K-ras gene 285
PDGF-B as a possible growth factor in AIDS-KS. 284
PROTECTIVE EFFECT OF INTERFERON-BETA ON HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I INFECTION OF CD4+ T-CELLS ISOLATED FROM HUMAN CORD-BLOOD 272
Prostaglandin E(2) induces apoptosis in resting immature and mature human lymphocytes: A c-Myc-dependent and Bcl-2-independent associated pathway 266
Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitro 259
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 112
Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O-6-methylguanine-DNA methyltransferase activity 94
Adjuvant therapy of melanoma patients (Stage II, III): a pilot immuno-toxicological study 79
Totale 33.040
Categoria #
all - tutte 51.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.634 0 0 0 0 0 0 0 0 0 793 951 890
2019/20208.778 785 778 627 802 796 944 766 760 720 673 528 599
2020/20214.778 533 562 468 647 473 501 623 484 108 100 213 66
2021/2022917 31 122 60 68 32 76 51 56 51 70 37 263
2022/20231.256 115 88 16 209 115 282 96 65 124 3 105 38
2023/2024476 62 10 28 11 52 194 76 33 4 6 0 0
Totale 33.040